HIV/AIDS Prevention
Researchers at University of California target HIV/AIDS prevention
Published in AIDS Weekly, December 24th, 2007
New research, 'A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients,' is the subject of a report. In this recent study, researchers in the United States conducted a study "To improve the utility of therapeutic drug monitoring (TDM) by defining the proportion of patients with and predictors of above or below target protease inhibitor (PI) or nonnucleoside reverse transcriptase inhibitor (NNRTI) concentrations. This 48-week, multicenter, open-label clinical trial randomized patients to TDM versus standard of care (SOC)."
"Serial pharmacokinetics, including a week-2 3-sample sparse collection, and expert...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-12-24)
More Articles from AIDS Weekly
- Cancer Vaccines
New study suggests why vaccines directed against cancer, HIV don't work - HIV/AIDS
Studies suggest HIV subtype more deadly than others - HIV/AIDS
Reports outline HIV/AIDS study findings from Khon Kaen University - HIV/AIDS Cancer
Research results from P.T. Pitche and co-authors update knowledge of HIV/AIDS cancer - HIV/AIDS Co-Infection
Findings from Y.H. Wang and co-researchers advance knowledge in HIV/AIDS co-infection - HIV/AIDS Co-Infection
Reports on HIV/AIDS co-infection findings from A. Mellgren and co-researchers provide new insights - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
